Literature DB >> 12792760

Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.

Yasuyoshi Fujiuchi1, Osamu Nagakawa, Koji Murakami, Hideki Fuse, Ikuo Saiki.   

Abstract

Hepatocyte growth factor (HGF) was suggested to play an important role in the regulation of mitogenesis, motogenesis, angiogenesis, migration and invasion for various types of cells, and acts through a specific membrane receptor encoded by c-met proto-oncogene. However, the mechanism of the effect of HGF on tumor invasion of prostate cancer cells remains unclear. We investigated the effect of HGF on the invasion of PC-3 and DU-145 prostate cancer cells through a reconstituted basement membrane (Matrigel), the haptotactic migration to fibronectin substrate, the expression of protein and mRNA for matrix metalloproteinases (MMP)-1 and -9, membrane-type 1-MMP (MT1-MMP), urokinase-type plasminogen activator (u-PA) and its receptor (uPAR). HGF increased both Matrigel invasion and haptotactic migration of prostate cancer cells. Furthermore, HGF also increased the production of MMP-1 and -9, MT1-MMP, u-PA and uPAR of these cells. These results suggested that HGF increased the invasive potential of prostate cancer cells probably through enhancement of cell motility and the production of MMPs and u-PA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12792760

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

1.  Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion.

Authors:  Apaporn Menakongka; Tuangporn Suthiphongchai
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

Review 2.  Molecular pathology of prostate cancer.

Authors:  C Hughes; A Murphy; C Martin; O Sheils; J O'Leary
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

3.  HGF upregulates CXCR4 expression in gliomas via NF-kappaB: implications for glioma cell migration.

Authors:  Mine Esencay; Elizabeth W Newcomb; David Zagzag
Journal:  J Neurooncol       Date:  2010-02-16       Impact factor: 4.130

4.  Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607.

Authors:  Yao Dai; Dietmar W Siemann
Journal:  BMC Cancer       Date:  2012-05-28       Impact factor: 4.430

5.  MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells.

Authors:  Soichiro Yamamura; Sharanjot Saini; Shahana Majid; Hiroshi Hirata; Koji Ueno; Guoren Deng; Rajvir Dahiya
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

6.  Activation of c-MET induces a stem-like phenotype in human prostate cancer.

Authors:  Geert J L H van Leenders; Rajesh Sookhlall; Wilma J Teubel; Corrina M A de Ridder; Suzanne Reneman; Andrea Sacchetti; Kees J Vissers; Wytske van Weerden; Guido Jenster
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

7.  Knockdown of WAVE3 impairs HGF induced migration and invasion of prostate cancer cells.

Authors:  Muhammad Moazzam; Lin Ye; Ping-Hui Sun; Howard Kynaston; Wen G Jiang
Journal:  Cancer Cell Int       Date:  2015-05-10       Impact factor: 5.722

8.  The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness.

Authors:  Ulrike Schmidt; Gerwin Heller; Gerald Timelthaler; Petra Heffeter; Zsolt Somodi; Norbert Schweifer; Maria Sibilia; Walter Berger; Agnes Csiszar
Journal:  J Exp Clin Cancer Res       Date:  2021-02-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.